Cargando…

Impact of COVID-19 pandemic on oncology clinical trial design, data collection and analysis

BACKGROUND: To identify and assess via simulation the impact of COVID-19 pandemic on oncology trials and discuss potential mitigation strategies for study design, data collection, endpoints and analyses. METHODS: We simulated clinical trials to evaluate the COVID-19 impact on overall survival and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Rui (Sammi), Zhu, Jian, Chen, Tai-Tsang, Liu, Fang, Jiang, Xun, Huang, Bo, Lee, J. Jack, Beckman, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935956/ https://www.ncbi.nlm.nih.gov/pubmed/35331946 http://dx.doi.org/10.1016/j.cct.2022.106736

Ejemplares similares

Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective
por: Ghadessi, Mercedeh, et al.
Publicado: (2023)

Collection of Post-treatment PRO Data in Oncology Clinical Trials
por: Lundy, J. Jason, et al.
Publicado: (2020)

Editorial: Data Based Radiation Oncology—Design of Clinical Trials
por: Kessel, Kerstin Anne, et al.
Publicado: (2018)

Statistical issues and challenges in immuno-oncology
por: Chen, Tai-Tsang
Publicado: (2013)

Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era
por: Azria, David, et al.
Publicado: (2017)

New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs
por: Beckman, Robert A., et al.
Publicado: (2013)

The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials
por: Ali, Jennyfa K., et al.
Publicado: (2021)

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments
por: Trapani, Dario, et al.
Publicado: (2022)

Basic Design Considerations for Clinical Trials in Oncology
por: Piantadosi, Steven, et al.
Publicado: (1992)

Master protocol trials in oncology: Review and new trial designs
por: Hirakawa, Akihiro, et al.
Publicado: (2018)

The design, analysis and application of mouse clinical trials in oncology drug development
por: Guo, Sheng, et al.
Publicado: (2019)

Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology
por: Kurtin, Sandra E., et al.
Publicado: (2020)

Spotlight on landmark oncology trials: the latest evidence and novel trial designs
por: Earl, Helena, et al.
Publicado: (2017)

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
por: Rich, Anna, et al.
Publicado: (2018)

Sexual Orientation and Gender Identity Data Collection in Oncology Practice: Findings of an ASCO Survey
por: Kamen, Charles S., et al.
Publicado: (2022)

Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology
por: Agostinelli, Veronica, et al.
Publicado: (2023)

A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
por: Chen, Jack, et al.
Publicado: (2013)

What are the methodological designs of nihr funded clinical trials? Going beyond routine data collection
por: Young, Amanda, et al.
Publicado: (2015)

EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting
por: Majeed, Habeeb, et al.
Publicado: (2018)

Challenges, opportunities, and innovative statistical designs for precision oncology trials
por: Yin, Jun, et al.
Publicado: (2022)

Considerations for designing trials targeting muscle dysfunction in exercise oncology
por: Brooks, Alexander, et al.
Publicado: (2023)

A hybrid design for dose‐finding oncology clinical trials
por: Liao, Jason J. Z., et al.
Publicado: (2022)

Barriers, facilitators, and recommendations for sexual orientation and gender identity data collection in community oncology practices
por: Mullins, Megan A., et al.
Publicado: (2023)

Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity
por: Kasim, Adetayo, et al.
Publicado: (2023)

Optimizing Trial Designs for Targeted Therapies
por: Ondra, Thomas, et al.
Publicado: (2016)

Managing oncology clinical trials during COVID-19 pandemic
por: Arai, Roberto J., et al.
Publicado: (2020)

Chinese Translation and Cross-Cultural Adaptation of the Return-to-Work Self-Efficacy Scale among Chinese Female Breast Cancer Survivors
por: Cheng, Andy S. K., et al.
Publicado: (2023)

Optimal, minimax and admissible two-stage design for phase II oncology clinical trials
por: Qin, Fei, et al.
Publicado: (2020)

The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial
por: Zhou, Megan S., et al.
Publicado: (2023)

Power and Design Issues in Crossover-Based N-Of-1 Clinical Trials with Fixed Data Collection Periods
por: Wang, Yanpin, et al.
Publicado: (2019)

Artificial Intelligence in Oncology: A Topical Collection in 2022
por: Stadlbauer, Andreas, et al.
Publicado: (2023)

Equality, diversity, and inclusion in oncology clinical trials: an audit of essential documents and data collection against INCLUDE under-served groups in a UK academic trial setting
por: Patel, Dhrusti, et al.
Publicado: (2023)

Assessing the impact of open-label designs in patient-reported outcomes: investigation in oncology clinical trials
por: Lord-Bessen, Jennifer, et al.
Publicado: (2023)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Designing circulating tumor DNA-based interventional clinical trials in oncology
por: Araujo, Daniel V., et al.
Publicado: (2019)

Ethical considerations of neuro-oncology trial design in the era of precision medicine
por: Gupta, Saksham, et al.
Publicado: (2017)

Early phase clinical trials in oncology: realising the potential of seamless designs
por: Jaki, Thomas, et al.
Publicado: (2023)

Optimal predictive probability designs for randomized biomarker-guided oncology trials
por: Zabor, Emily C., et al.
Publicado: (2022)

Design, power, and alpha levels in randomized phase II oncology trials
por: Haslam, A., et al.
Publicado: (2023)

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
por: Farah, Eliya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qn10v8nem800m2q03mk6ri9rus